143 related articles for article (PubMed ID: 17174383)
1. Prognostic significance of iNOS in epithelial ovarian cancer.
Anttila MA; Voutilainen K; Merivalo S; Saarikoski S; Kosma VM
Gynecol Oncol; 2007 Apr; 105(1):97-103. PubMed ID: 17174383
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer.
Sillanpää S; Anttila M; Voutilainen K; Ropponen K; Turpeenniemi-Hujanen T; Puistola U; Tammi R; Tammi M; Sironen R; Saarikoski S; Kosma VM
Gynecol Oncol; 2007 Feb; 104(2):296-303. PubMed ID: 17034838
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.
Zafirellis K; Zachaki A; Agrogiannis G; Gravani K
APMIS; 2010 Feb; 118(2):115-24. PubMed ID: 20132175
[TBL] [Abstract][Full Text] [Related]
4. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
[TBL] [Abstract][Full Text] [Related]
5. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
6. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH
Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150
[TBL] [Abstract][Full Text] [Related]
7. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
[TBL] [Abstract][Full Text] [Related]
10. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.
Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP
Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962
[TBL] [Abstract][Full Text] [Related]
13. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
Gynecol Oncol; 2004 Mar; 92(3):806-12. PubMed ID: 14984945
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
15. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
Qiao YH; Cheng J; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
[TBL] [Abstract][Full Text] [Related]
16. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
17. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
Gao GL; Liu LD; Zou XS; Chen WX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma SH; Lipponen PK; Kosma VM
Anticancer Res; 2001; 21(4B):3101-6. PubMed ID: 11712818
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z
Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279
[TBL] [Abstract][Full Text] [Related]
20. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y
Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
